Retracted Apigenin induces apoptosis and counteracts cisplatin‑induced chemoresistance via Mcl‑1 in ovarian cancer cells

Key Points

• Apigenin effectively induces apoptosis in ovarian cancer cells, combating cisplatin-induced chemoresistance.
• The mechanism involves modulation of Mcl-1, suggesting a new therapeutic target for overcoming treatment resistance.
• Cisplatin, a common chemotherapy drug, faces challenges due to resistance, making apigenin's role crucial in treatment strategies.
• These findings support future investigations on apigenin's potential in clinical applications for ovarian cancer.